Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Date Issued
Submitting OIG
Department of Health & Human Services OIG
Other Participating OIGs
Department of Health & Human Services OIG
Agencies Reviewed/Investigated
Department of Health & Human Services
Report Number
A-07-18-06079
Report Description

For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program’s drug rebate requirements, manufacturers must pay rebates to the States for the drugs. However, a prior OIG review found that States did not always invoice and collect all rebates due for drugs administered by physicians.Our objective was to determine whether Maine complied with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs.

Report Type
Audit
Location

ME,
United States

Number of Recommendations
5
Questioned Costs
$4,281,213
Funds for Better Use
$10,801,067

Department of Health & Human Services OIG

United States